Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: A prospective study

Diabetes Care

Volumn 22, Issue 9, 1999, Pages 1401-1407

  Samaras, Katherine ^b   Hayward, Christopher S ^b   Sullivan, David ^b   Kelly, Raymond P ^b   Campbell, Lesley V ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CONJUGATED ESTROGEN; FAT; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE; METFORMIN; SEX HORMONE BINDING GLOBULIN; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; EXERCISE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; WELLBEING;

EID: 0032820322     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.9.1401     Document Type: Article

References (50)

1. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM: Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 96:88-98, 1995
2. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ: Abdominal fat and insulin resistance in normal and overweight women: direct measures reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638, 1996
3. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjöström L: Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obesity 13:413-423, 1989
4. Lapidus L, Bengtsson C, Larson B, Pennert K, Rybo E, Sjöstrom L: Distribution of adipose tissue and risk of cardiovascular disease: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289:1261-1263, 1984
5. Poehlman ET, Toth MJ, Gardner AW: Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 123:673-675, 1995
6. Svendsen OL, Hassager C, Christiansen C: Age-and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy x-ray absorptiometry. Metabolism 44:369-373, 1995
7. Haarbo J, Marslew U, Gotfredsen A, Christiansen C: Postmenopausal hormone replacement therapy prevents central distribution of body fat after the menopause. Metabolism 40:1323-1326, 1991
8. Samaras K, Kelly PJ, Spector TD, Chiano MN, Campbell LV: Tobacco smoking and oestrogen replacement are associated with lower total and central fat in monozygotic twins. Int J Obes 22:149-156, 1998
9. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH: A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313:1044-1049, 1985
10. Wilson PWF, Garrison RJ, Castelli WP: Postmenopausal estrogen use, cigarette smoking, and cardiovascular mortality in women over 50: the Framingham Study N Engl J Med 313:1038-1043, 1985
11. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH: Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335: 453-461, 1996
12. Criqui MH, Suarez L, Barrett-Connor E, McPhillips J, Wingard DL, Garland C: Postmenopausal estrogen use and mortality: results from a prospective study in a defined homogeneous community. Am J Epidemiol 128:606-614, 1988
13. Barrett-Connor E, Cohn BB, Wingard DL, Edelstein SL: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 265:627-631, 1991
14. Sattar N, Jaap AJ, MacCuish AC: Hormone replacement therapy and cardiovascular risk on post-menopausal women with NIDDM. Diabet Med 13:782-788, 1996
15. Dunne FP: Should women with diabetes mellitus receive hormone replacement therapy? Int J Clin Pract 51:299-303, 1997
16. Feher MD, Isaacs AJ: Is hormone replacement therapy prescribed for postmenopausal diabetic women? Brit J Clin Pract 50:431-432, 1996
17. Moorhead T, Hannaford P, Warskyj M: Prevalence and characteristics associated with hormone replacement therapy in Britain. Br J Obstet Gynaecol 104:290-297, 1997
18. Brussard HE, Gevers Leuven JA, Kluft C, Krans MJ, van Duyvenvoorde W, Buytenhek R, van der Laarse A, Princen HMG: Effect of 17β-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus. Arterioscler 17:324-330, 1997
19. Andersson B, Mattsson L-A, Hahn L, Mårin P, Lapidus L, Holm G, Bengtsson B-A, Björntorp P: Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes. J Clin Endocrinol Metab 82:638-643, 1997
20. Brussard HE, Gevers Leuven JA, Frölich M, Kluft C, Krans HMJ: Short-term oestrogen replacement improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40: 843-849, 1997
21. Samaras K, Spector TD, Nguyen TV, Baan K, Campbell LV, Kelly PJ: Independent genetic factors determine the amount and distribution of fat in women after the menopause. J Clin Endocrinol Metab 82: 781-785, 1997
22. Campbell LV, Carey DG, Chisholm DJ: Measuring central fat: a bet each way? Diabetes Care 19:1033-1034, 1996
23. McNamara JR, Schaefer EJ: Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Chim Clin Acta 166:1-8, 1987
24. Blanche PJ, Gong EM, Forte TL, Nichols AV: Characterisation of human high density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 665:408-419, 1981
25. Hayward CS, Knight DC, Wren BR, Kelly RP: The effect of hormone replacement therapy on noninvasive cardiovascular hemodynamics. J Hypertens 15:987-993, 1997
26. Wicks J: Guide to Exercise. Canberra, Australia, National Heart Foundation of Australia, 1983
27. Jenkinson C, Coulter A, Wright L: Short Form 36 (SF 36) health survey questionnaire: normative data for adults of working age BMJ 306:1437-1444, 1993
28. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204, 1991
29. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328: 1069-1075, 1993
30. Barrett-Connor E, Wingard DL, Criqui MH: Postmenopausal estrogen use and heart disease risk factors in the 1980s: Rancho Bernardo, Calif, revisited. JAMA 261: 2095-2100, 1989
31. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 273:199-208, 1995
32. Darling GM, Johns JA, McCloud PI, Davis SR: Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med 337:595-601, 1997
33. Gangar KF, Reid BA, Crook D, Hillard TC, Whitehead M: Oestrogens and atherosclerotic vascular disease: local vascular factors. Bailliére's Clin Endocrinol Metab 7:47-59, 1993
34. Salomaa V, Rasi V, Pekkanen J, Vahtera E, Jauhianen M, Vartiainen E, Ehnholm C, Tuomilehto J, Myllylä G: Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors: the FINRISK Hemostasis Study. Arterioscler Thromb Vasc Biol 15:1549-1555, 1995
35. Koh KK, Mincemoyer R, Bui MH, Csako G, Pucino F, Guetta V, Waclwiw M, Cannon RO: Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med 336:683-690, 1997
36. Fröhlich M, Schunkert H, Hense H-W, Tropitzsch A, Hendricks P, Döring A, Riegger GAJ , Koenig W: Effect of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal women. Br J Haematol 100:577-581, 1998
37. Sullivan JM, Vander Zwaag R, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM: Estrogen replacement and coronary artery disease. Arch Intern Med 150:2557-2562, 1990
38. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO: Acute vascular effects of estrogen in postmenopausal women. Circulation 90:786-791, 1994
39. Rosano GM, Sarrell PM, Poole-Wilson PA, Collins P: Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342:133-136, 1993
40. O'Keefe JH, Kim SC, Hall RR, Cochran VC, Lawhorn SL, McCallister BD: Estrogen therapy after coronary angioplasty in women. J Am Coll Cardiol 29:1-5, 1997
41. Sullivan JM, El-Zeky F, Vander Zwaag R, Ramanathan KB: Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol 79: 847-850, 1997
42. Robinson JG, Folsom AR, Nabulsi AA, Watson R, Brancati FL, Cai J, for the Atherosclerosis Risk in Communities Study: Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? Diabetes Care 19:480-485, 1996
43. Lehmann ED, Hopkins KD, Parker JR, Turay RC, Rymer J, Fogelman I, Gosling RG: Aortic distensibility in postmenopausal women receiving tibolone. Br J Radiol 67:701-705, 1994
44. Kritz-Silverstein D, Barrett-Connor E: Long-term postmenopausal hormone use, obesity and fat distribution in older women. JAMA 275:46-49, 1996
45. Khoo S-K, Coglan MJ, Wright GR, De Voss KN, Battistuta D: Hormone therapy in women in the menopause transition: randomised, double-blind, placebo-controlled trial of the effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity and the endometrium. Med J Aust 168:216-220, 1989
46. Berman RE, Epstein RS, Lydick E: Risk factors associated with women's compliance with estrogen replacement therapy. J Women's Health 6:219-226, 1997
47. Rebuffe-Scrivé M, Enk L, Crona N, Lönnroth P, Abrahamson L, Smith U, Björntorp P: Fat cell metabolism in different regions in women: effect of menstrual cycle, pregnancy, lactation. J Clin Invest 75:1973-1976, 1985
48. Rebuffe-Scrivé M, Lönnroth P, Mårin P, Wesslau C, Bjórntorp P, Smith U: Regional adipose tissue metabolism in men and postmenopausal women. Int J Obes 11: 347-355, 1987
49. Jenkins AB, Storlein LH, Chisholm DJ, Kraegen EW: Effects of non-esterified fatty acid availability on tissue-specific glucose utilization in rats in vivo. J Clin Invest 82:293-299. 1988
50. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 45:3-10, 1997